E. Ohman J or Asset Management AB Has $51.74 Million Stock Holdings in Colgate-Palmolive Company $CL

E. Ohman J or Asset Management AB lifted its stake in Colgate-Palmolive Company (NYSE:CL) by 14.8% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 564,311 shares of the company’s stock after acquiring an additional 72,576 shares during the quarter. Colgate-Palmolive makes up approximately 1.2% of E. Ohman J or Asset Management AB’s investment portfolio, making the stock its 14th largest position. E. Ohman J or Asset Management AB’s holdings in Colgate-Palmolive were worth $51,736,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Teacher Retirement System of Texas increased its stake in shares of Colgate-Palmolive by 35.3% during the 4th quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company’s stock worth $37,110,000 after purchasing an additional 122,634 shares during the last quarter. Flputnam Investment Management Co. lifted its stake in Colgate-Palmolive by 7.4% in the 4th quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company’s stock valued at $15,881,000 after purchasing an additional 13,804 shares during the last quarter. SEB Asset Management AB acquired a new stake in Colgate-Palmolive in the 1st quarter valued at about $91,149,000. Caprock Group LLC grew its holdings in Colgate-Palmolive by 116.5% during the fourth quarter. Caprock Group LLC now owns 64,808 shares of the company’s stock worth $5,121,000 after purchasing an additional 34,879 shares during the period. Finally, Conning Inc. increased its position in Colgate-Palmolive by 10.2% during the fourth quarter. Conning Inc. now owns 426,753 shares of the company’s stock worth $33,722,000 after buying an additional 39,655 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have issued reports on CL shares. Sanford C. Bernstein assumed coverage on Colgate-Palmolive in a research note on Thursday, June 11th. They issued a “market perform” rating and a $96.00 price objective on the stock. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $104.00 to $103.00 and set an “overweight” rating on the stock in a report on Monday, August 3rd. Barclays increased their price target on Colgate-Palmolive from $80.00 to $87.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 21st. Citigroup raised their price target on Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Finally, UBS Group lifted their price objective on shares of Colgate-Palmolive from $106.00 to $109.00 and gave the stock a “buy” rating in a research report on Monday, August 3rd. Twelve equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $99.00.

Colgate-Palmolive Stock Down 0.3%

CL stock opened at $92.97 on Tuesday. The company has a debt-to-equity ratio of 13.82, a current ratio of 1.03 and a quick ratio of 0.67. The stock has a market capitalization of $74.11 billion, a price-to-earnings ratio of 36.89, a PEG ratio of 4.55 and a beta of 0.33. The business’s fifty day moving average price is $91.22 and its two-hundred day moving average price is $89.83. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The company had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $5.36 billion. During the same quarter in the previous year, the business posted $0.92 earnings per share. Colgate-Palmolive’s quarterly revenue was up 4.9% on a year-over-year basis. On average, equities analysts anticipate that Colgate-Palmolive Company will post 3.86 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be paid a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s payout ratio is 84.13%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 161,021 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total value of $14,801,050.32. Following the completion of the sale, the chief executive officer owned 362,231 shares of the company’s stock, valued at $33,296,273.52. The trade was a 30.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director John T. Cahill sold 4,170 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total transaction of $389,352.90. Following the transaction, the director directly owned 28,373 shares in the company, valued at $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.43% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.